We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+1.21%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$693M
AUM Growth
-$53.2M
Cap. Flow
+$17M
Cap. Flow %
2.45%
Top 10 Hldgs %
46.29%
Holding
382
New
110
Increased
31
Reduced
28
Closed
176

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$32.7M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$18.7M
3
DIS icon
Walt Disney
DIS
+$14.1M
4
TSM icon
TSMC
TSM
+$6.86M
5
AMZN icon
Amazon
AMZN
+$6.38M

Sector Composition

Rank Sector Weight
1 Technology 13.91%
2 Communication Services 5.2%
3 Healthcare 1.02%
4 Materials 0.39%
5 Utilities 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JCI icon
51
CALL
Johnson Controls International
JCI
$86.4B
$2.4M 0.35%
37,500
ADP icon
52
PUT
Automatic Data Processing
ADP
$110B
$2.39M 0.34%
10,000
-8,000
-44% -$1.96M
MPT
53
PUT
Medical Properties Trust
MPT
$2.85B
$2.28M 0.33%
204,900
-177,700
-46% -$2.07M
BNDD icon
54
Quadratic Deflation ETF
BNDD
$24.8M
$2.26M 0.33%
+18,750
New +$3.09M
ALB icon
55
CALL
Albemarle
ALB
$13.5B
$2.17M 0.31%
+10,000
New +$2.67M
NBIS
56
CALL
Nebius Group N.V.
NBIS
$39.4B
$1.97M 0.28%
103,800
AMD icon
57
PUT
Advanced Micro Devices
AMD
$724B
$1.94M 0.28%
+30,000
New +$1.98M
SGEN
58
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
$1.93M 0.28%
15,000
+7,500
+100% +$968K
ETSY icon
59
CALL
Etsy
ETSY
$8.21B
$1.8M 0.26%
15,000
HZNP
60
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.78M 0.26%
+15,600
New +$1.3M
EOG icon
61
PUT
EOG Resources
EOG
$77.2B
$1.68M 0.24%
13,000
-48,400
-79% -$6.44M
CME icon
62
CALL
CME Group
CME
$95.2B
$1.68M 0.24%
+10,000
New +$1.74M
HZNP
63
PUT
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.66M 0.24%
+14,600
New +$1.21M
AKRO
64
CALL
DELISTED
Akero Therapeutics
AKRO
$1.64M 0.24%
30,000
+22,300
+290% +$955K
AKRO
65
PUT
DELISTED
Akero Therapeutics
AKRO
$1.64M 0.24%
30,000
+22,300
+290% +$955K
NVCR icon
66
CALL
NovoCure
NVCR
$1.78B
$1.61M 0.23%
+22,000
New +$1.66M
MAXR
67
CALL
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$1.55M 0.22%
+29,900
New +$821K
TGTX icon
68
CALL
TG Therapeutics
TGTX
$8.36B
$1.54M 0.22%
129,900
+100,000
+334% +$726K
LAC
69
PUT
DELISTED
Lithium Americas Corp. Common Shares
LAC
$1.52M 0.22%
+80,000
New +$1.94M
PINS icon
70
CALL
Pinterest
PINS
$13.7B
$1.46M 0.21%
60,000
-30,000
-33% -$716K
EIX icon
71
Edison International
EIX
$30.4B
$1.44M 0.21%
+22,700
New +$1.39M
EIX icon
72
PUT
Edison International
EIX
$30.4B
$1.44M 0.21%
+22,700
New +$1.39M
AEM icon
73
PUT
Agnico Eagle Mines
AEM
$73.1B
$1.42M 0.21%
27,400
SLB icon
74
PUT
SLB Ltd
SLB
$73.5B
$1.34M 0.19%
25,000
FLNA
75
CALL
Filana Therapeutics
FLNA
$42M
$1.26M 0.18%
42,700
+22,300
+109% +$801K

Similar funds

SG3 Management's Q4 2022 Portfolio in Review

As of Q4 2022, SG3 Management held 382 positions worth $693M, down 7.1% from $746M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

SG3 Management's Q4 2022 filing shows 110 new, 31 increased, 28 reduced and 176 closed positions. Its largest new stake was Alphabet (Google) Class A: 232,500 shares worth $20.5M. The largest sale was Tesla, an estimated $32.7M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 3.7% a quarter earlier, followed by Communication Services and Healthcare.

  • SG3 Management's largest Q4 2022 buy was Alphabet (Google) Class A: 232,500 shares worth $20.5M.
  • SG3 Management added most to Microsoft in Q4 2022, an estimated $85.8M increase.
  • SG3 Management's biggest Q4 2022 reduction was Tesla, cutting an estimated $32.7M.
  • SG3 Management fully exited Alphabet (Google) Class C in Q4 2022, selling an estimated $18.7M.
  • SG3 Management's ten largest holdings make up 46% of its $693M portfolio in Q4 2022.
  • SG3 Management opened 110 new positions and closed 176 in Q4 2022.
  • SG3 Management's portfolio value fell 7.1% quarter-over-quarter to $693M.

Based on SG3 Management's 13F filing for Q4 2022, filed 14 Feb 2023.